Leading Medical Communications Group Aims for 50% Reduction by 2030


London, UK | July 27, 2021

Medical communications group AS&K has set ambitious emissions reduction goals using the Science Based Target initiative’s (SBTi) framework for SMEs. This global organization provides companies with a clearly de?ned pathway to future-proof growth by specifying how much and how quickly they need to reduce their greenhouse gas (GHG) emissions.

By joining more than 1,000 visionary businesses from all industries including major pharmaceutical companies, AS&K is leading the way in the medical communication sector in this important worldwide e?ort to tackle the climate crisis. AS&K has set a group-wide goal of 50% reduction in GHG emissions, which is in line with the most stringent goal of the Paris Agreement to keep global warming to 1.5C and prevent the most damaging e?ects of climate change.

“AS&K understands the urgent need for companies to take action to address the climate crisis. We’re absolutely committed to doing all that we can, and will also work with our clients to reduce the climate impact of their medical communication activities,”  said Simon Gee,  AS&K Agency Head.

As well as reducing emissions, AS&K is aiming to become net zero before 2030 by supporting programs that mitigate the e?ects of their remaining emissions.

“The climate crisis is one of the most important issues of our times and we’re passionate about taking meaningful steps to reduce our carbon footprint. Joining the SBTi and setting emissions reduction goals is a critical ?rst step in getting to net-zero as soon as we can,” added Katherine Vik, Senior Digital Project Manager and Chair of AS&K’s Climate Committee. “We are also running a number of workstreams to help our clients reduce the environmental impact of their medical communications.”

More information about AS&K’s commitment is available on the SBTi website.

About AS&K Group: The AS&K Group is an independently owned group of medical communications agencies who collaborate with leading pharmaceutical and medical device companies. As strategic partners and subject matter experts, the AS&K Group transforms complex scienti?c information into compelling programs that inform and educate healthcare professionals. The AS&K Group comprises three innovative companies: Remedica, AS&K Communications and The Corpus. Follow our journey on Twitter @asandkgroup and Linkedin

Contact Details

AS&K Group

Alana Zdinak

+44 7766 706656



Alejandro Potes

+44 20 7428 2996


Company Website


Agencia EFE S.A. no se hace responsable de la información que contiene este mensaje y no asume responsabilidad alguna frente a terceros sobre su íntegro contenido, quedando igualmente exonerada de la responsabilidad de la entidad autora del mismo.